Today's Updates

Winter Sports and Lower Limb Motor Disability
Published Date: 16 Mar 2026

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Read More
Can Better Screening Prevent Maternal VTE Deaths?
Published Date: 16 Mar 2026

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

Read More
'Concerning': CRC Continues to Shift Toward Younger Adults
Published Date: 16 Mar 2026

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

Read More
Tight Glycemic Target in Gestational Diabetes Reduces Risks
Published Date: 16 Mar 2026

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Read More

Latest News

Study shows Ozempic could help dialysis patients qualify for kidney transplants

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney transplant. New research from Saint Louis University School of Medicine and SSM Health physicians ...

How do I know if my kid is worrying about food and their body too much? And what should I say?

Eating disorders are most likely to develop in young people aged between 12 and 25.

Understudied eating disorder matches anorexia, bulimia severity

A diagnosis often viewed as less serious than anorexia and bulimia—and the most common eating disorder worldwide—can cause just as much harm, a new study has found.

Popular weight-loss drugs show added heart protection for diabetes patients

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this ...

Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes medication metformin in addition to standard care, according to a preliminary, late-breaking science ...

Mandatory nutrient warning labels could prevent 100,000+ obesity-related deaths

Researchers from the University of Liverpool have found that making front-of-pack nutrition labeling mandatory could significantly reduce obesity rates and save thousands of lives across England.

Is it healthier to only eat until you're 80% full? The Japanese philosophy of hara hachi bu

Some of the world's healthiest and longest-living people follow the practice of "hara hachi bu"—an eating philosophy rooted in moderation. This practice comes from a Japanese Confucian teaching which instructs people to ...

Obesity treatment in the UK risks becoming a two-tier system, researchers warn

Treatment for obesity in the UK could become a two-tier system where the most vulnerable patients miss out altogether.

Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called ...

Combination of obesity and poor sleep increases risk of multiple chronic diseases

People with poor sleep and obesity have a much higher risk of multimorbidity—having two or more chronic diseases at the same time—University of Queensland researchers have found.

The first child-specific body scan charts could enable physicians to assess obesity risk

A Concordia-led research team has created one of the first reference charts showing how children's adipose (fat) and muscle levels change with age and sex—a breakthrough that could help identify young people at risk for ...

In Mississippi, Medicaid coverage of weight loss drugs fails to catch on

In a state where the obesity rate ranks among the highest in the country, many health providers were thrilled when Mississippi Medicaid in 2023 began covering GLP-1s for people 12 and older. Only 13 states cover the drugs ...

Brain scans may predict future weight gain in people with mental disorders

With a simple standard MRI scan of the brain, it may soon be possible to predict which people with mental illnesses will gain weight after their initial diagnosis—thereby increasing their risk of physical diseases—and ...

New blood-based biomarkers could help predict bariatric surgery outcomes in teens

A USC-led team has developed an innovative way to predict blood pressure outcomes after bariatric surgery that outperforms the current standard practice. In 108 adolescents who underwent bariatric surgery, the researchers ...

Counting bites with AI might one day help prevent childhood obesity

The faster a child takes bites during a meal or snack, the greater risk they have for developing obesity, according to researchers in the Penn State Department of Nutritional Sciences. But research into this association is ...

Obesity remains high in the US., but more states are showing progress, a new report finds

For the first time in more than a decade, the number of states with rates of obesity of 35% or more dropped, an encouraging sign that America's epidemic of excess weight might be improving. But cuts to federal staff and programs ...

Latest News

Study shows Ozempic could help dialysis patients qualify for kidney transplants

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney transplant. New research from Saint Louis University School of Medicine and SSM Health physicians ...

How do I know if my kid is worrying about food and their body too much? And what should I say?

Eating disorders are most likely to develop in young people aged between 12 and 25.

Understudied eating disorder matches anorexia, bulimia severity

A diagnosis often viewed as less serious than anorexia and bulimia—and the most common eating disorder worldwide—can cause just as much harm, a new study has found.

Popular weight-loss drugs show added heart protection for diabetes patients

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this ...

Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes medication metformin in addition to standard care, according to a preliminary, late-breaking science ...

Mandatory nutrient warning labels could prevent 100,000+ obesity-related deaths

Researchers from the University of Liverpool have found that making front-of-pack nutrition labeling mandatory could significantly reduce obesity rates and save thousands of lives across England.

Is it healthier to only eat until you're 80% full? The Japanese philosophy of hara hachi bu

Some of the world's healthiest and longest-living people follow the practice of "hara hachi bu"—an eating philosophy rooted in moderation. This practice comes from a Japanese Confucian teaching which instructs people to ...

Obesity treatment in the UK risks becoming a two-tier system, researchers warn

Treatment for obesity in the UK could become a two-tier system where the most vulnerable patients miss out altogether.

Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called ...

Combination of obesity and poor sleep increases risk of multiple chronic diseases

People with poor sleep and obesity have a much higher risk of multimorbidity—having two or more chronic diseases at the same time—University of Queensland researchers have found.

The first child-specific body scan charts could enable physicians to assess obesity risk

A Concordia-led research team has created one of the first reference charts showing how children's adipose (fat) and muscle levels change with age and sex—a breakthrough that could help identify young people at risk for ...

In Mississippi, Medicaid coverage of weight loss drugs fails to catch on

In a state where the obesity rate ranks among the highest in the country, many health providers were thrilled when Mississippi Medicaid in 2023 began covering GLP-1s for people 12 and older. Only 13 states cover the drugs ...

Brain scans may predict future weight gain in people with mental disorders

With a simple standard MRI scan of the brain, it may soon be possible to predict which people with mental illnesses will gain weight after their initial diagnosis—thereby increasing their risk of physical diseases—and ...

New blood-based biomarkers could help predict bariatric surgery outcomes in teens

A USC-led team has developed an innovative way to predict blood pressure outcomes after bariatric surgery that outperforms the current standard practice. In 108 adolescents who underwent bariatric surgery, the researchers ...

Counting bites with AI might one day help prevent childhood obesity

The faster a child takes bites during a meal or snack, the greater risk they have for developing obesity, according to researchers in the Penn State Department of Nutritional Sciences. But research into this association is ...

Obesity remains high in the US., but more states are showing progress, a new report finds

For the first time in more than a decade, the number of states with rates of obesity of 35% or more dropped, an encouraging sign that America's epidemic of excess weight might be improving. But cuts to federal staff and programs ...

News All Time

Five reasons we shouldn't 'compliment' people who lose weight

"You look so great! Have you lost weight?"

Nearly 70% of US adults meet new definition of obesity, study finds

The prevalence of obesity in the United States could rise sharply under a definition of obesity released earlier this year by the Lancet Diabetes and Endocrinology Commission.

BMI shouldn't be the only way to assess who can access weight-loss drugs

About 1 in 3 Australian adults (32%) has a body-mass index (BMI) of 30 or above. A further 34% has a BMI of 25 or above.

Diets high in ultra-processed foods are bad for us, so why are we eating more?

Aussies eat more ultra-processed foods than ever before, with busy lifestyles and personal choices often taking the blame as casual factors.

Weight loss drug stigma shows society still holds negative attitudes towards body weight and obesity

Since Wegovy received approval as a weight loss treatment in 2021, there has been huge demand for GLP-1 drugs. These drugs reduce hunger and suppress the "food noise" that can make it difficult to lose weight.

Two in three people with chronic pain turn to comfort eating

More than two-thirds of people living with chronic pain reach for chocolate or other comfort foods to cope, with new research showing that eating offers pleasure, distraction and relief from negative emotions during pain ...

Gaps and opportunities in precision medicine approach to obesity treatment identified

A new report led by researchers at Pennington Biomedical Research Center underscores the growing potential of precision medicine to transform how obesity is prevented, diagnosed and treated, while also illuminating key gaps ...

Think your BMI reflects your health? Think again, study warns

As new Statistics Canada data reveals that two-thirds of Canadians are considered overweight or obese, researchers are urging the public and policymakers to rethink how we define and measure health—starting with one of ...

Use of weight loss drugs before bariatric surgery has soared in recent years, study finds

New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric surgery, signaling an evolution in the management of obesity and type 2 diabetes.

Research highlights the need for culturally specific screening tools

Despite research finding a higher prevalence of eating disorders among Aboriginal youth in Australia, new research from Edith Cowan University (ECU) published in the Journal of Eating Disorders has revealed a lack of culturally ...

Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity and its complications from ...

Weight-loss surgery could help boost work productivity

A new international QUT-led study found that bariatric surgery improves work productivity and employment rates in the short term—but these gains may not last beyond five years without targeted support.

Reducing risk of eating disorders by controlling peer and family pressures

Weight-related peer teasing is a strong predictor of disordered eating behaviors in adolescents, particularly those at higher genetic risk, new research shows.

Study suggests new drug for weight loss may cause fewer side effects

A new Penn Nursing study suggests that the weight-loss drug tirzepatide may cause fewer side effects like nausea and vomiting than the drug semaglutide. This research, published in Science Advances, was conducted using preclinical ...

Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers

Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.

Too heavy for medical care: Over 40% of specialty clinics turn away patients weighing 465 pounds

Patients weighing 450 pounds or more face barriers and discrimination when scheduling or attending doctor visits at subspecialty practices, reports a new Northwestern Medicine study.

Recommended News For You

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

Cancer mortality continuing to decline, says report

Alkem introduces cetuximab under the trade name Cetuxa in India.

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

Recommended Articles For You

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations 

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

2.

Treating Depression: Crucial for Recovery From Fibromyalgia

3.

Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.

4.

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

5.

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

1.

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer

2.

Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education

3.

Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights

4.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

5.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Thromboprophylaxis In Medical Settings

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

4.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot